Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 20 October 2009
Vol. 2, Issue 93, p. ra66
[DOI: 10.1126/scisignal.2000387]
RESEARCH ARTICLES
Editor's Summary
A One-Two Punch
Members of the interleukin-1 (IL-1) family of cytokines stimulate proinflammatory responses through their activation of the transcription factors nuclear factor B (NF-B) and activating protein 1 (AP-1). The binding of IL-1 to its receptor complex triggers the activation of the E3 ubiquitin ligase and scaffold protein TRAF6 and its association with the mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) TAK1, which leads to the activation of NF-B. Another MAP3K, MEKK3, is also involved in IL-1–mediated activation of NF-B, but how TAK1 and MEKK3 might physically or functionally interact has been unclear. Yamazaki et al. showed that early IL-1 signaling induced the formation of a transient complex of TRAF6, TAK1, and MEKK3. Formation of this complex, which was dependent on TRAF6-mediated ubiquitination of TAK1, led to NF-B activation. In a later phase of IL-1 signaling, TRAF6 activated NF-B in a MEKK3-dependent, TAK1-independent manner. Together, these two pathways resulted in the prolonged activation of NF-B required to trigger an effective proinflammatory response.
Citation: K. Yamazaki, J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, J.-i. Inoue, Two Mechanistically and Temporally Distinct NF-B Activation Pathways in IL-1 Signaling. Sci. Signal.2, ra66 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PERSPECTIVES
Bahram Razani and Genhong Cheng (7 September 2010) Sci. Signal.3 (138), pe29.
[DOI: 10.1126/scisignal.3138pe29] |Abstract »|Full Text »|PDF »
EDITORIAL GUIDES
John F. Foley and Nancy R. Gough (19 January 2010) Sci. Signal.3 (105), eg2.
[DOI: 10.1126/scisignal.3105eg2] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Shelly M. Wuerzberger-Davis and Shigeki Miyamoto (19 January 2010) Sci. Signal.3 (105), pe3.
[DOI: 10.1126/scisignal.3105pe3] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
NF-{kappa}B Is the Transcription Factor for FGF-2 That Causes Endothelial Mesenchymal Transformation in Cornea.
J. G. Lee and E. P. Kay (2012)
Invest. Ophthalmol. Vis. Sci.
53, 1530-1538
|Abstract »|Full Text »|PDF »
Polyubiquitination of Transforming Growth Factor {beta} (TGF{beta})-associated Kinase 1 Mediates Nuclear Factor-{kappa}B Activation in Response to Different Inflammatory Stimuli.
A. Hamidi, V. von Bulow, R. Hamidi, N. Winssinger, S. Barluenga, C.-H. Heldin, and M. Landstrom (2012)
J. Biol. Chem.
287, 123-133
|Abstract »|Full Text »|PDF »
TAK1 in brain endothelial cells mediates fever and lethargy.
D. A. Ridder, M.-F. Lang, S. Salinin, J.-P. Roderer, M. Struss, C. Maser-Gluth, and M. Schwaninger (2011)
J. Exp. Med.
208, 2615-2623
|Abstract »|Full Text »|PDF »
Activation of the I{kappa}B kinase complex by HTLV-1 Tax requires cytosolic factors involved in Tax-induced polyubiquitination.
Y. Shibata, Y. Tanaka, J. Gohda, and J.-i. Inoue (2011)
J. Biochem.
150, 679-686
|Abstract »|Full Text »|PDF »
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1.
D. Melisi, Q. Xia, G. Paradiso, J. Ling, T. Moccia, C. Carbone, A. Budillon, J. L. Abbruzzese, and P. J. Chiao (2011)
J Natl Cancer Inst
103, 1190-1204
|Abstract »|Full Text »|PDF »
MEKK3 Regulates IFN-{gamma} Production in T Cells through the Rac1/2-Dependent MAPK Cascades.
X. Wang, F. Zhang, F. Chen, D. Liu, Y. Zheng, Y. Zhang, C. Dong, and B. Su (2011)
J. Immunol.
186, 5791-5800
|Abstract »|Full Text »|PDF »
The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-{kappa}B Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atherosclerosis.
T. W. Kim, M. Febbraio, P. Robinet, B. DuGar, D. Greene, A. Cerny, E. Latz, R. Gilmour, K. Staschke, G. Chisolm, et al. (2011)
J. Immunol.
186, 2871-2880
|Abstract »|Full Text »|PDF »
H. H. Cheung, S. T. Beug, M. St. Jean, A. Brewster, N. L. Kelly, S. Wang, and R. G. Korneluk (2010)
J. Biol. Chem.
285, 40612-40623
|Abstract »|Full Text »|PDF »
Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
J. Gautheron, A. Pescatore, F. Fusco, E. Esposito, S. Yamaoka, F. Agou, M. V. Ursini, and G. Courtois (2010)
Hum. Mol. Genet.
19, 3138-3149
|Abstract »|Full Text »|PDF »
A. L. Borikova, C. F. Dibble, N. Sciaky, C. M. Welch, A. N. Abell, S. Bencharit, and G. L. Johnson (2010)
J. Biol. Chem.
285, 11760-11764
|Abstract »|Full Text »|PDF »